Table 7. Stage-specific overall survival for neuroendocrine carcinomas.
| Overall survival | Stage I | Stage II | Stage III | Stage IV |
|---|---|---|---|---|
| 1-year OS | 97.4% | 100% | 90.7% | 54.8% |
| 2-year OS | 92.6% | 93.5% | 90.7% | 54.8% |
| 3-year OS | 92.6% | 93.5% | 90.7% | 27.4% |
| 4-year OS | 92.6% | 93.5% | 90.7% | 27.4% |